TTPH Insider Trading Activity and SEC Form 4 Filings
TTPH insider trading summary
No open-market insider purchases or sales of Tetraphase Pharmaceuticals Inc (TTPH) have been reported on SEC Form 4 in the past 12 months.
Latest TTPH insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 28, 2020 | La Jolla Pharmaceutical Co | 10% Owner | Buy | $7.5M (3,737,360 @ $2.00) |
| Jun 19, 2020 | La Jolla Pharmaceutical Co | 10% Owner | Buy | $614K (234,698 @ $2.62) |
| Dec 10, 2019 | John Gordon Freund | Director | Sell | $32K (14,507 @ $2.19) |
| Dec 10, 2019 | John Gordon Freund | Director | Sell | $1K (524 @ $2.19) |
| Dec 6, 2019 | Guy Macdonald | Director | Sell | $13K (5,734.65 @ $2.25) |
| Dec 5, 2019 | Guy Macdonald | Director | Sell | $4K (1,870.35 @ $2.34) |
| Jan 8, 2019 | Jacques Dumas | Chief ScientificOfficer | Sell | $12K (7,497 @ $1.60) |
| Jan 30, 2018 | Jacques Dumas | Chief ScientificOfficer | Sell | $54K (8,750 @ $6.22) |
| Jan 9, 2018 | Jacques Dumas | Chief ScientificOfficer | Sell | $45K (7,167 @ $6.21) |
| Nov 29, 2017 | L Patrick Gage | Director | Buy | $25K (3,880 @ $6.45) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.